Global BCG Vaccine Market Growth 2023-2029

Global BCG Vaccine Market Growth 2023-2029

BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
LPI (LP Information)' newest research report, the “BCG Vaccine Industry Forecast” looks at past sales and reviews total world BCG Vaccine sales in 2022, providing a comprehensive analysis by region and market sector of projected BCG Vaccine sales for 2023 through 2029. With BCG Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world BCG Vaccine industry.
This Insight Report provides a comprehensive analysis of the global BCG Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on BCG Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global BCG Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for BCG Vaccine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global BCG Vaccine.
The global BCG Vaccine market size is projected to grow from US$ 365.6 million in 2022 to US$ 542.8 million in 2029; it is expected to grow at a CAGR of 542.8 from 2023 to 2029.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Immune BCG
Therapy BCG
Segmentation by application
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Key Questions Addressed in this Report
What is the 10-year outlook for the global BCG Vaccine market?
What factors are driving BCG Vaccine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do BCG Vaccine market opportunities vary by end market size?
How does BCG Vaccine break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.